Novel Pharmacotherapies for Recurrent Pericarditis: Current Options in 2020

ABSTRACT: Recent advances have shown impressive results by anti-interleukin 1 (IL-1) agents in refractory idiopathic recurrent pericarditis. PURPOSE OF REVIEW: We critically discuss the current state of the art of therapy of relapsing pericarditis, with a focus on new pharmacological approaches and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tombetti, Enrico, Mulè, Alice, Tamanini, Silvia, Matteucci, Luca, Negro, Enrica, Brucato, Antonio, Carnovale, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Pericardial Disease (AL Klein and CL Jellis, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303578/
https://www.ncbi.nlm.nih.gov/pubmed/32562029
http://dx.doi.org/10.1007/s11886-020-01308-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303578/
https://www.ncbi.nlm.nih.gov/pubmed/32562029
http://dx.doi.org/10.1007/s11886-020-01308-y

Ejemplares similares